Embraer S.A.
EMBJEmbraer S.A.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
Biggest watch item: the price is already 3 weeks into its uptrend — timing risk, not thesis risk.
The price is in a confirmed uptrend (3 weeks in). Underneath, the last four quarters read improving — profit −50.0% year on year, and 231% of the last 3 years' profit arrived as cash. What settles it: the next one or two quarters of delivery.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Embraer S.A. trades at $70.5, in a confirmed uptrend and 3 weeks into that stage. That is +9.0% against its own 200-day average. It sits at 66% of a 52-week range of $55 to $79. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 3 straight weeks.
Today the stock is in a confirmed uptrend — week 3 of stage 2. At $70.5 it trades +9.0% versus its 200-day average and sits at 66% of its 52-week range ($55–$79).
Against the market, two honest reads. Cumulative: over the last 10.1 years the stock moved +227% while the S&P 500 moved +263% — behind the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 3 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
Embraer S.A. trades at 38.8× P/E, against too little history to rank. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 38.8× is against too little history to rank. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +0.0% against a +24.1% price move — the price outran earnings, pushing the multiple UP its own range.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Embraer S.A. reads as mixed on its fundamental arc. Mixed — no clean majority across the growth curves, ROCE holding at 7.6% — the per-curve reads carry the story. The read is built from 12 quarters across 3 curves, on partial evidence.
Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +18.6% | +18.6% | — | — |
| Profit | −76.3% | — | — | — |
| EPS | +0.0% | — | — | — |
| Stock price | +24.1% | +69.8% | +37.0% | +14.4% |
4-Factor Sector Score
53.0/100 — rank 12 of 30 in Aerospace & Defense · 66% evidence confidence
Embraer S.A. scores 53.0 out of 100 against the 30 companies it is compared with in Aerospace & Defense, ranking 12. Price leads the evidence: RS versus the benchmark is 0.2%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
The four contributions add to the total exactly: 16.3 + 7.9 + 14.3 + 14.5 = 53. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Embraer S.A. reported $1.4 B of revenue in the Mar 26 quarter, +31.8% year on year. That is the 12th straight quarter of year-on-year growth. Over 4 years it has compounded at 15.9% a year. The last full year, FY25, came in at $7.6 B. The last four reported quarters add to $8.0 B.
FY25 revenue came in at $7.6 B (+18.6% on the year), capping 4 years at 15.9% compound. The latest quarter (Mar 26) printed $1.4 B, +31.8% year on year — the 12th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +21.8% growth against the decade's 15.9% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +20.2% over the last 4 quarters against +20.5%/yr over the last 8 — stabilising; TTM profit −20.0% vs +10.9%/yr — rolling over.
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Embraer S.A.'s operating margin is 5.5% in the Mar 26 quarter, +1.0 percentage points against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −2.4% to 10.5%. The current quarter sits inside that band.
The latest quarter's operating margin is 5.5%, +1.0 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −2.4%–10.5%.
Why the margin moved: operating margin went +1.0 pp year on year while gross margin went +0.6 pp — the gain came mostly from the gross line: input costs and pricing.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Embraer S.A. earned $0.0 B of net profit in the Mar 26 quarter, −50.0% year on year. Full-year FY25 profit was $0.2 B. That is 2.8% of the quarter's revenue. The same quarter a year earlier earned $0.1 B. 1 of the last 12 reported quarters were loss-making.
Mar 26 profit was $0.0 B, −50.0% year on year. On the full year, FY25 printed $0.2 B (−76.3%).
🚨 Why profit moved: revenue contributed +31.8% and the margin +1.0 pp — the quarter was revenue-led, with the margin roughly flat.
Pace comparison, last four quarters: profit −1.9% vs revenue +21.8%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 231% of Embraer S.A.'s reported profit arrived as operating cash — the cash follows the profit. In FY25 that was $0.9 B of operating cash against $0.2 B of profit. After $0.2 B of capital spending, $0.7 B was left as free cash.
FY25: operating cash of $0.9 B against reported profit of $0.2 B, leaving free cash of $0.7 B after $0.2 B of capital spending. Across the last 3 fiscal years the conversion rate is 231% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Embraer S.A. does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $1.0 B over the last 3 years. Averaged over those years that is 4.4% of FY25 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $1.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
Embraer S.A. earns a ROE of 5% in FY25. That is up from a trough of −7% in FY22. Return on invested capital clears the cost of that capital by +7.0 percentage points, so growth here adds value rather than only size. The wiring behind it is 2.4% net margin on 0.59× asset turns.
FY25 ROE is 5%, recovered from a FY22 trough of −7% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY25): 2.4% net margin × 0.59× asset turns × 3.39× balance-sheet leverage ≈ 4.8% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 14.9% − 7.9% = a +7.0 pp spread. The 7.9% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. A spread this wide means every dollar reinvested creates more than a dollar of value — the engine compounds.
Dividend A dividend is cash paid out per share. Dividend per share is the declared amount for the period; the trailing twelve-month total is the four most recent quarters added together.
Embraer S.A. has 2 quarters of declared dividends on file — too few for a trailing-twelve-month figure. The most recent declaration was $0.72 for Dec 25.
Embraer S.A. has declared a dividend in 2 of the last 12 reported quarters, most recently $0.72 for Dec 25. That is fewer than four quarters, so no trailing-twelve-month total is shown rather than one built from a partial year.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Embraer S.A. carries total debt of $2.8 B against shareholder equity of $3.7 B as of Mar 26, a debt-to-equity of 0.77. On the annual view that ratio went from 0.74 in FY21 to 0.71 in FY25. Read the returns elsewhere on this page with that leverage in mind.
Mar 26: total debt of $2.8 B against shareholder equity of $3.7 B — a debt-to-equity of 0.77. On the annual view, debt-to-equity went from 0.74 (FY21) to 0.71 (FY25). Read the returns on this page with that leverage in mind.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
No ownership or positioning reading is held for Embraer S.A., so this section names the gap rather than filling it. At typical trading volumes those positions would take about 1.9 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
We hold no ownership or positioning reading for this stock, so this section says that plainly.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Embraer S.A.: the Z-score reads 1.78. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits inside the distress zone. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
🚨 Why it matters: a Z-score of 1.78 is inside the distress zone — the balance sheet is a real risk, not a detail.
The safety line in one sentence: the Z-score reads 1.78.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1HEICO CorporationHEI | 67.7/100Favorable setup81% evidence | BREAKING OUT | 24.4/35 Revenue 18.8% · PAT 30.2% · OPM change 2.9 pp 83% evidence | 15.5/25 ROCE 4.3% · OPM 25.5% 76% evidence | 10.5/20 P/E 48.2× · PEG 1.56 65% evidence | 17.3/20 RS sector 5% · RS bench 3.6% · 1Y 17.3%8 of 12 weeks ahead 100% evidence |
| Exact sum: 24.4 + 15.5 + 10.5 + 17.3 = 67.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Howmet Aerospace Inc.HWM | 65.9/100Favorable setup66% evidence | TURNING | 22.6/35 Revenue 14.2% · PAT 38.9% · OPM change 7.2 pp 53% evidence | 15.9/25 ROCE 7.5% · OPM 32.6% 57% evidence | 11.2/20 P/E 53.5× · PEG 1.32 65% evidence | 16.2/20 RS sector 16.2% · RS bench 13.9% · 1Y 59.4%2 of 12 weeks ahead 100% evidence |
| Exact sum: 22.6 + 15.9 + 11.2 + 16.2 = 65.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Elbit Systems Ltd.ESLT | 59.7/100Mixed-positive evidence66% evidence | TURNING | 20.6/35 Revenue 14.8% · PAT 66.9% · OPM change 1.5 pp 53% evidence | 12.3/25 ROCE 3.1% · OPM 9.4% 57% evidence | 11.6/20 P/E 68.8× · PEG 1.21 65% evidence | 15.2/20 RS sector 16.5% · RS bench 13.3% · 1Y 89%0 of 12 weeks ahead 100% evidence |
| Exact sum: 20.6 + 12.3 + 11.6 + 15.2 = 59.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Lockheed Martin CorporationLMT | 59.3/100Thin evidence · provisional56% evidence | TURNING | 19.6/35 Revenue — · PAT — · OPM change -1.8 pp 39% evidence | 15.2/25 ROCE 6.8% · OPM 11.4% 76% evidence | 11.1/20 P/E 18.7× · PEG — 15% evidence | 13.4/20 RS sector 1.2% · RS bench -1.1% · 1Y 38.5%3 of 12 weeks ahead 100% evidence |
| Exact sum: 19.6 + 15.2 + 11.1 + 13.4 = 59.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 5Hexcel CorporationHXL | 58.7/100Thin evidence · provisional56% evidence | FADING | 21.0/35 Revenue — · PAT — · OPM change 1.8 pp 39% evidence | 11.4/25 ROCE 2.9% · OPM 11.5% 76% evidence | 9.8/20 P/E 50.3× · PEG — 15% evidence | 16.5/20 RS sector 17.4% · RS bench 15.2% · 1Y 72.6%8 of 12 weeks ahead 100% evidence |
| Exact sum: 21 + 11.4 + 9.8 + 16.5 = 58.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 6RTX CorporationRTX | 58.2/100Thin evidence · provisional56% evidence | TURNING | 19.1/35 Revenue — · PAT — · OPM change 1.6 pp 39% evidence | 10.6/25 ROCE 2.5% · OPM 11.6% 76% evidence | 10.8/20 P/E 33.4× · PEG — 15% evidence | 17.7/20 RS sector 8.6% · RS bench 6.5% · 1Y 40.7%3 of 12 weeks ahead 100% evidence |
| Exact sum: 19.1 + 10.6 + 10.8 + 17.7 = 58.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 7GE AerospaceGE | 57.7/100Mixed-positive evidence81% evidence | BREAKING OUT | 18.8/35 Revenue 21.7% · PAT 18.8% · OPM change 0.3 pp 83% evidence | 11.8/25 ROCE 2.9% · OPM 18.9% 76% evidence | 8.6/20 P/E 43.9× · PEG 2.09 65% evidence | 18.5/20 RS sector 10.7% · RS bench 9% · 1Y 37.2%8 of 12 weeks ahead 100% evidence |
| Exact sum: 18.8 + 11.8 + 8.6 + 18.5 = 57.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Woodward, Inc.WWD | 56.9/100Thin evidence · provisional56% evidence | ASLEEP | 20.5/35 Revenue — · PAT — · OPM change 1.2 pp 39% evidence | 15.1/25 ROCE 4.9% · OPM 14.7% 76% evidence | 9.7/20 P/E 50.5× · PEG — 15% evidence | 11.6/20 RS sector 4.5% · RS bench 2.1% · 1Y 50.5%3 of 12 weeks ahead 100% evidence |
| Exact sum: 20.5 + 15.1 + 9.7 + 11.6 = 56.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 9Leonardo DRS, Inc.DRS | 55.2/100Thin evidence · provisional56% evidence | TURNING | 20.7/35 Revenue — · PAT — · OPM change 1.7 pp 39% evidence | 12.4/25 ROCE 3.3% · OPM 9.1% 76% evidence | 10.5/20 P/E 35.9× · PEG — 15% evidence | 11.6/20 RS sector -0.5% · RS bench -2.1% · 1Y 9.1%2 of 12 weeks ahead 100% evidence |
| Exact sum: 20.7 + 12.4 + 10.5 + 11.6 = 55.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 10General Dynamics CorporationGD | 54.9/100Thin evidence · provisional56% evidence | BREAKING OUT | 17.3/35 Revenue — · PAT — · OPM change 0.5 pp 39% evidence | 13.1/25 ROCE 3.7% · OPM 10.5% 76% evidence | 11.0/20 P/E 22.8× · PEG — 15% evidence | 13.5/20 RS sector 1.5% · RS bench -0.1% · 1Y 22.8%3 of 12 weeks ahead 100% evidence |
| Exact sum: 17.3 + 13.1 + 11 + 13.5 = 54.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 11Curtiss-Wright CorporationCW | 54.2/100Mixed-positive evidence66% evidence | ASLEEP | 18.8/35 Revenue 12.2% · PAT 19.1% · OPM change 1.5 pp 53% evidence | 14.1/25 ROCE 4% · OPM 17.5% 57% evidence | 7.3/20 P/E 49.9× · PEG 2.33 65% evidence | 14.0/20 RS sector 9.1% · RS bench 6.8% · 1Y 60.3%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.8 + 14.1 + 7.3 + 14 = 54.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Embraer S.A.this pageEMBJ | 53.0/100Mixed-positive evidence66% evidence | TURNING | 16.3/35 Revenue 20% · PAT -22.2% · OPM change 1 pp 53% evidence | 7.9/25 ROCE 1.1% · OPM 5.6% 57% evidence | 14.3/20 P/E 54.9× · PEG 0.51 65% evidence | 14.5/20 RS sector 1.9% · RS bench 0.2% · 1Y 20.8%2 of 12 weeks ahead 100% evidence |
| Exact sum: 16.3 + 7.9 + 14.3 + 14.5 = 53 · Decision use: Price leads the evidence: RS versus the benchmark is 0.2%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 13StandardAero, Inc.SARO | 52.4/100Thin evidence · provisional56% evidence | TURNING | 18.3/35 Revenue 15% · PAT 100% · OPM change -0.2 pp 53% evidence | 9.5/25 ROCE 2.8% · OPM 8.8% 57% evidence | 10.9/20 P/E 29.4× · PEG — 15% evidence | 13.7/20 RS sector 0.7% · RS bench -1% · 1Y 11.3%3 of 12 weeks ahead 100% evidence |
| Exact sum: 18.3 + 9.5 + 10.9 + 13.7 = 52.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 14Axon Enterprise, Inc.AXON | 48.0/100Thin evidence · provisional56% evidence | BREAKING OUT | 19.3/35 Revenue 34% · PAT -37.8% · OPM change 5.1 pp 53% evidence | 8.1/25 ROCE 0.6% · OPM 3.6% 57% evidence | 8.6/20 P/E 170.6× · PEG — 15% evidence | 12.0/20 RS sector -1.7% · RS bench -2.1% · 1Y -27.9%6 of 12 weeks ahead 100% evidence |
| Exact sum: 19.3 + 8.1 + 8.6 + 12 = 48 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 15TransDigm Group IncorporatedTDG | 44.8/100Mixed-negative evidence66% evidence | TURNING | 16.2/35 Revenue 13.3% · PAT 9.6% · OPM change 0.2 pp 53% evidence | 15.6/25 ROCE 5.5% · OPM 46.3% 57% evidence | 5.7/20 P/E 35.6× · PEG 4.36 65% evidence | 7.3/20 RS sector -10.2% · RS bench -11.3% · 1Y -8.3%0 of 12 weeks ahead 100% evidence |
| Exact sum: 16.2 + 15.6 + 5.7 + 7.3 = 44.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Northrop Grumman CorporationNOC | 44.8/100Thin evidence · provisional56% evidence | BASING | 17.4/35 Revenue — · PAT — · OPM change 3.9 pp 39% evidence | 11.2/25 ROCE 3% · OPM 10% 76% evidence | 11.5/20 P/E 16.2× · PEG — 15% evidence | 4.7/20 RS sector -16.6% · RS bench -18.2% · 1Y -5.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 17.4 + 11.2 + 11.5 + 4.7 = 44.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 17Huntington Ingalls Industries, Inc.HII | 42.5/100Thin evidence · provisional56% evidence | ASLEEP | 16.5/35 Revenue — · PAT — · OPM change -0.9 pp 39% evidence | 9.5/25 ROCE 2.2% · OPM 5% 76% evidence | 11.4/20 P/E 16.7× · PEG — 15% evidence | 5.1/20 RS sector -11.3% · RS bench -13.5% · 1Y 22.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 16.5 + 9.5 + 11.4 + 5.1 = 42.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 18CAE Inc.CAE | 42.3/100Mixed-negative evidence66% evidence | BASING | 10.5/35 Revenue 4.4% · PAT -22.4% · OPM change -7.6 pp 53% evidence | 10.8/25 ROCE 2% · OPM 12.9% 57% evidence | 14.8/20 P/E 37.3× · PEG 0.68 65% evidence | 6.2/20 RS sector -11.8% · RS bench -13.2% · 1Y -6.2%0 of 12 weeks ahead 100% evidence |
| Exact sum: 10.5 + 10.8 + 14.8 + 6.2 = 42.3 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 19Textron Inc.TXT | 41.5/100Thin evidence · provisional56% evidence | BASING | 15.6/35 Revenue — · PAT — · OPM change -0.8 pp 39% evidence | 9.4/25 ROCE 2% · OPM 6.3% 76% evidence | 11.3/20 P/E 17.4× · PEG — 15% evidence | 5.2/20 RS sector -7.9% · RS bench -9.5% · 1Y 15.7%1 of 12 weeks ahead 100% evidence |
| Exact sum: 15.6 + 9.4 + 11.3 + 5.2 = 41.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 20The Boeing CompanyBA | 39.9/100Thin evidence · provisional56% evidence | BASING | 16.4/35 Revenue — · PAT — · OPM change -0.4 pp 39% evidence | 4.6/25 ROCE 0.3% · OPM 2% 76% evidence | 9.0/20 P/E 93.7× · PEG — 15% evidence | 9.9/20 RS sector -1.6% · RS bench -3.1% · 1Y 3.5%0 of 12 weeks ahead 100% evidence |
| Exact sum: 16.4 + 4.6 + 9 + 9.9 = 39.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 21FTAI Aviation Ltd.FTAI | 39.8/100Thin evidence · provisional56% evidence | ASLEEP | 12.5/35 Revenue — · PAT — · OPM change -9.6 pp 39% evidence | 14.3/25 ROCE 5% · OPM 20.5% 76% evidence | 9.2/20 P/E 58.8× · PEG — 15% evidence | 3.8/20 RS sector -5.3% · RS bench -7.9% · 1Y 63.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 12.5 + 14.3 + 9.2 + 3.8 = 39.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 22L3Harris Technologies, Inc.LHX | 39.7/100Thin evidence · provisional53% evidence | BASING | 17.9/35 Revenue — · PAT — · OPM change 1.2 pp 32% evidence | 10.3/25 ROCE 1.9% · OPM 11.4% 76% evidence | 8.9/20 P/E 96× · PEG — 15% evidence | 2.6/20 RS sector -15.5% · RS bench -17.3% · 1Y 5.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 17.9 + 10.3 + 8.9 + 2.6 = 39.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 23AeroVironment, Inc.AVAV | 37.3/100Mixed-negative evidence71% evidence | BASING | 17.6/35 Revenue 100% · PAT -702.3% · OPM change 3.9 pp 83% evidence | 6.4/25 ROCE 1.8% · OPM 8.9% 76% evidence | 8.7/20 P/E 97.8× · PEG — 15% evidence | 4.6/20 RS sector -36.8% · RS bench -37.6% · 1Y -31.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 17.6 + 6.4 + 8.7 + 4.6 = 37.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24BWX Technologies, Inc.BWXT | 34.2/100Adverse evidence66% evidence | BASING | 16.3/35 Revenue 21.4% · PAT 19% · OPM change -1.8 pp 53% evidence | 11.4/25 ROCE 2.7% · OPM 9.9% 57% evidence | 5.3/20 P/E 54.7× · PEG 2.86 65% evidence | 1.2/20 RS sector -18% · RS bench -19.5% · 1Y -3.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 16.3 + 11.4 + 5.3 + 1.2 = 34.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 25Kratos Defense & Security Solutions, Inc.KTOS | 33.9/100Thin evidence · provisional56% evidence | BASING | 18.0/35 Revenue 21.9% · PAT 50% · OPM change -0.9 pp 53% evidence | 6.6/25 ROCE 0.2% · OPM 1.3% 57% evidence | 8.5/20 P/E 423.2× · PEG — 15% evidence | 0.8/20 RS sector -36.5% · RS bench -37.9% · 1Y -18.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18 + 6.6 + 8.5 + 0.8 = 33.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 26Planet Labs PBCPL | 30.2/100Adverse evidence61% evidence | ASLEEP | 13.8/35 Revenue 34% · PAT — · OPM change -2.7 pp 62% evidence | 3.4/25 ROCE -4.8% · OPM -37.1% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 3.0/20 RS sector -6.5% · RS bench -9.9% · 1Y 256.7%4 of 12 weeks ahead 100% evidence |
| Exact sum: 13.8 + 3.4 + 10 + 3 = 30.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 27Honeywell Aerospace Inc.HONA | 55.0/100Thin evidence · provisional18% evidence | 17.7/35 Revenue — · PAT — · OPM change -4.3 pp 10% evidence | 17.3/25 ROCE 14.4% · OPM 20.2% 57% evidence | 10.0/20 P/E — · PEG — 0% evidence | 10.0/20 RS sector — · RS bench — · 1Y — 0% evidence | |
| Exact sum: 17.7 + 17.3 + 10 + 10 = 55 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 28Moog Inc.MOG-B | 54.0/100Thin evidence · provisional33% evidence | BREAKING OUT | 19.6/35 Revenue — · PAT — · OPM change 1 pp 32% evidence | 14.0/25 ROCE 4.4% · OPM 10.8% 76% evidence | 10.4/20 P/E 36.1× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y 101.5%8 of 11 weeks ahead 0% evidence |
| Exact sum: 19.6 + 14 + 10.4 + 10 = 54 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 29Rocket Lab CorporationRKLB | 42.4/100Thin evidence · provisional48% evidence | FADING | 22.4/35 Revenue 45.7% · PAT — · OPM change 20.4 pp 40% evidence | 6.0/25 ROCE -3.4% · OPM -27.9% 57% evidence | 10.0/20 P/E — · PEG — 0% evidence | 4.0/20 RS sector -5.1% · RS bench -7.4% · 1Y 66.6%8 of 12 weeks ahead 100% evidence |
| Exact sum: 22.4 + 6 + 10 + 4 = 42.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 30Space Exploration Technologies Corp.SPCX | 41.7/100Thin evidence · provisional18% evidence | 16.3/35 Revenue — · PAT — · OPM change -42.1 pp 10% evidence | 5.4/25 ROCE -5% · OPM -41.4% 57% evidence | 10.0/20 P/E — · PEG — 0% evidence | 10.0/20 RS sector — · RS bench — · 1Y — 0% evidence | |
| Exact sum: 16.3 + 5.4 + 10 + 10 = 41.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Embraer S.A.'s stock price today?
Embraer S.A. trades at $70.5, +24.1% over the past year. The company is valued at $13.0 B. The stock sits at 66% of its 52-week range of $55–$79, +9.0% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 3 weeks in. — as of 5 August 2026.
What were Embraer S.A.'s latest quarterly results?
Embraer S.A. reported revenue of $1.4 B and net profit of $0.0 B for the Mar 26 quarter. Revenue rose 31.8% and profit fell 50.0% year on year. Earnings per share were $0.19. The operating margin was 5.5%, 1.0 pp higher than a year earlier. — as of 5 August 2026.
What is Embraer S.A.'s revenue?
Embraer S.A. reported revenue of $1.4 B in the Mar 26 quarter, +31.8% year on year. For the full FY25 fiscal year, revenue was $7.6 B (+18.6%). Over the last 4 years revenue compounded at 15.9% a year. — as of 5 August 2026.
What is Embraer S.A.'s profit?
Embraer S.A. earned $0.0 B of net profit in the Mar 26 quarter, −50.0% year on year. Full-year FY25 profit was $0.2 B. The operating margin ran 5.5% in the latest quarter. — as of 5 August 2026.
What is Embraer S.A.'s market cap?
Embraer S.A.'s market capitalisation is $13.0 B at a stock price of $70.5. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.
Does Embraer S.A. pay a dividend?
Yes — Embraer S.A. declared $0.72 per share for Dec 25 (2 quarters on file, too few for a trailing-twelve-month total). The latest quarter is up 922.2% on the same quarter a year earlier. — as of 5 August 2026.
What is Embraer S.A.'s dividend per share?
Embraer S.A.'s most recently declared dividend is $0.72 per share for Dec 25. Each figure is the amount declared for that quarter as reported, added across four quarters for the trailing total. — as of 5 August 2026.
Is Embraer S.A. growing?
Yes — Embraer S.A. is growing: latest-quarter revenue +31.8% year on year, profit −50.0%, and the margin +1.0 pp at 5.5%. The earnings engine currently reads: improving — as of 5 August 2026.
How is Embraer S.A. performing?
Embraer S.A. is in a confirmed uptrend, 3 weeks in. Its latest quarter's revenue rose 31.8% and profit fell 50.0% year on year. Against the S&P 500 it has been ahead on a trailing-13-week view for 3 weeks. This describes what the data did, not a rating. — as of 5 August 2026.
What stage is Embraer S.A. in?
Mixed — no clean majority across the growth curves, ROCE holding at 7.6% — the per-curve reads carry the story. The read comes from the last 12 quarters of growth (revenue growth +20.2% latest, profit growth −50.0% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 5 August 2026.
Is Embraer S.A. in an uptrend?
Yes — the price is in a confirmed uptrend (week 3 of stage 2), trading +9.0% versus its 200-day average and at 66% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 5 August 2026.
Is Embraer S.A. beating the market?
On recent form, yes — Embraer S.A. has been ahead of the S&P 500 on a trailing-13-week view for 3 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.1 years the stock moved +227% against the S&P 500's +263% — behind the index over the full window. — as of 5 August 2026.
Will Embraer S.A.'s stock price go up?
This page publishes no price forecast for Embraer S.A. What it measures instead: the stock price is $70.5, the price is in a confirmed uptrend 3 weeks in. Direction is not something this site claims to know. — as of 5 August 2026.
Does Embraer S.A. have too much debt?
It is moderate — Embraer S.A.'s debt-to-equity is 0.78. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. Read the returns on this page with that leverage in mind — as of 5 August 2026.
What is Embraer S.A.'s capex?
Embraer S.A. spent $1.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.2 B. — as of 5 August 2026.
What is Embraer S.A.'s cash flow?
Embraer S.A. generated $0.9 B of operating cash flow in FY25 and $0.7 B of free cash flow after $0.2 B of capital spending. Reported profit that year was $0.2 B, so operating cash ran ahead of profit. — as of 5 August 2026.
Is Embraer S.A.'s profit real cash?
Yes — over the last 3 fiscal years, 231% of Embraer S.A.'s reported profit arrived as operating cash. In FY25, operating cash was $0.9 B against reported profit of $0.2 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 5 August 2026.
How financially safe is Embraer S.A.?
On the balance sheet, the Z-score reads 1.78 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That is inside the danger band — a real balance-sheet risk. — as of 5 August 2026.
Where is Embraer S.A. in its business cycle?
Embraer S.A.'s FY25 operating margin was 8.0%, against a 5-year band of −2.4%–10.5%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 5.5%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.
What could break the Embraer S.A. story?
Biggest watch item: the price is already 3 weeks into its uptrend — timing risk, not thesis risk. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.
Is Embraer S.A. a stock worth studying right now?
This is not investment advice. The machine read: Embraer S.A.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.